Ronjon Nag

Ronjon Nag General Information

Description

Dr. Ronjon Nag is a Co-Founder and serves as Chairman at capAI. He serves as Chairman at Boomerang Bike. He is a Co-Founder and serves as Chief Executive Officer & Board Member at Agemica. He is a Co-Founder and serves as Chief Executive Officer and President at Ikshana Therapeutics. He founded Brightswitch. He served as Board Member, Board Observer & Advisor at Celeris Therapeutics. He is an inventor, teacher, and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science, and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm that invests in and creates AI and Longevity companies. As an AI pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently, he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the $1m Verizon Powerful Answers Award, the 2023 COX AI Lifetime Achievement Award, the 2023 MIT Great Dome Award, and is the 2024 Inductee in the Silicon Valley Engineering Hall of Fame. The professor has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology, and a B.Sc. from Birmingham in the UK.